AdipoGen Life Sciences


CHF 45.00
In stock
AG-CR1-2902-M0011 mgCHF 45.00
AG-CR1-2902-M0055 mgCHF 90.00
AG-CR1-2902-M02525 mgCHF 270.00
More Information
Product Details
Synonyms [9,9'-Bi-9H-fluorene]-9,9'-dicarboxaldehyde; NSC 610970
Product Type Chemical


MW 386.4
CAS 1176-09-6
Purity Chemicals ≥98% (NMR)
Appearance Beige solid.
Solubility Soluble in DMSO.
Identity Determined by 1H-NMR.
Other Product Data

Note: Use fresh solutions. Cyclizes in water/acidic conditions.

Smiles O=CC1(C2(C=O)C3=C(C=CC=C3)C4=C2C=CC=C4)C5=C(C=CC=C5)C6=C1C=CC=C6
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Keep cool and dry.
Keep under inert gas.
Protect from moisture and oxygen.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
  • Rapid apoptosis inducer that initiates intrinsic pathway caspase-dependent apoptosis within minutes in multiple cell lines and in vivo systems. Exerts anticancer activity in vivo, likely through the induction of apoptosis.
  • Induces cell death against various cancer and non-cancerous cell lines with 24 hour IC50 values between 0.7-3.4μM indicating activity across a wide range of cell lines.
  • Activates the intrinsic pathway and requires functional mitochondria for apoptosis induction. Treated cells did not undergo mitochondrial-permeability-transition-pore (MPTP) formation, suggesting a mitochondrial outer membrane permeabilization (MOMP) model of cytochrome c release.
  • This caspase-3 activator induced Gasdermin-E (GSDME)-dependent pyroptosis in naive and therapy-resistant melanoma.
Product References
  1. A small molecule that induces intrinsic pathway apoptosis with unparalleled speed: R. Palchaudhuri, et al.; Cell Rep. 13, 2027 (2015)
  2. The inflammasome drives GSDMD-independent secondary pyroptosis and IL-1 release in the absence of caspase-1 protease activity: K.S. Schneider, et al.; Cell Rep. 21, 3846 (2017)
  3. Raptinal induces Gasdermin E-dependent pyroptosis in naïve and therapy-resistant melanoma: M. Vernon, et al.; Mol. Cancer Res. 20, 1811 (2022)
  4. Tyrosine kinase inhibitors can activate the NLRP3 inflammasome in myeloid cells through lysosomal damage and cell lysis: E. Neuwirt, et al.; Sci. Signal. 16, 768 (2023)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.